BNC Korea Co., Ltd. (256840.KQ)

KRW 4160.0

(-1.42%)

Total Debt Summary of BNC Korea Co., Ltd.

  • BNC Korea Co., Ltd.'s latest annual total debt in 2023 was 737.2 Million KRW , down -94.64% from previous year.
  • BNC Korea Co., Ltd.'s latest quarterly total debt in 2024 Q2 was 10.1 Billion KRW , up 879.31% from previous quarter.
  • BNC Korea Co., Ltd. reported annual total debt of 13.74 Billion KRW in 2022, down -73.92% from previous year.
  • BNC Korea Co., Ltd. reported annual total debt of 52.7 Billion KRW in 2021, up 113.65% from previous year.
  • BNC Korea Co., Ltd. reported quarterly total debt of 1.04 Billion KRW for 2024 Q1, up 42.39% from previous quarter.
  • BNC Korea Co., Ltd. reported quarterly total debt of 13.47 Billion KRW for 2023 Q1, down -1.98% from previous quarter.

Annual Total Debt Chart of BNC Korea Co., Ltd. (2023 - 2016)

Historical Annual Total Debt of BNC Korea Co., Ltd. (2023 - 2016)

Year Total Debt Total Debt Growth
2023 737.2 Million KRW -94.64%
2022 13.74 Billion KRW -73.92%
2021 52.7 Billion KRW 113.65%
2020 24.66 Billion KRW 35.99%
2019 18.14 Billion KRW 68.47%
2018 10.76 Billion KRW 599.23%
2017 1.53 Billion KRW 2.15%
2016 1.5 Billion KRW 0.0%

Peer Total Debt Comparison of BNC Korea Co., Ltd.

Name Total Debt Total Debt Difference
HLB Pharmaceutical Co., Ltd 23.72 Billion KRW 96.893%
CMG Pharmaceutical Co., Ltd. 19.74 Billion KRW 96.266%
Celltrion Pharm, Inc. 162.52 Billion KRW 99.546%
Huons Global Co., Ltd. 254.93 Billion KRW 99.711%
DongKook Pharmaceutical Co., Ltd. 104.74 Billion KRW 99.296%
Enzychem Lifesciences Corporation 5.65 Billion KRW 86.968%
Humedix Co., Ltd. 2.7 Billion KRW 72.714%
Boditech Med Inc. 10.56 Billion KRW 93.024%
EuBiologics Co., Ltd. 14.77 Billion KRW 95.012%
FutureChem Co.,Ltd 3.68 Billion KRW 79.981%
Huons Co., Ltd. 124.61 Billion KRW 99.408%
AptaBio Therapeutics Inc. 13.93 Billion KRW 94.709%